Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,026,557
+$762,654 QoQ
Shares Held
111,639
+25.0% QoQ
Ownership
0.254%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 256 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. TARS ranks #40 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in TARS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,026,557 111,639
2026-03-31 $6,263,903 89,293
2025-12-31 $9,748,468 119,058
2025-09-30 $5,868,770 98,751
2025-06-30 $5,142,864 126,953
2025-03-31 $3,074,133 59,843
2024-12-31 $3,156,309 57,004
2024-09-30 $1,300,896 39,553
2024-06-30 $366,467 13,483
2024-03-31 $431,618 11,874
2023-12-31 $199,725 9,863
2023-09-30 $130,146 7,324
2023-06-30 $175,079 9,689
2023-03-31 $50,404 4,010
2022-12-31 $43,144 2,943
2022-09-30 $53,174 3,106
2022-06-30 $44,456 3,045
2022-03-31 $79,271 4,713
2021-12-31 $172,214 7,654
2021-09-30 $210,843 9,784
2021-03-31 $62,558 1,941
2020-12-31 $131,966 3,193